MRK
Merck & Company Inc
Merck & Company Inc historical holders
total: 18
Causeway Capital Management Merck & Company Inc transactions over time
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 5
- Held since:
- 2024 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2026 Q1
Sarah Ketterer has been an institutional investor in Merck & Company Inc (MRK) since 2019 Q1. According to 2026 Q1 report, Sarah Ketterer holds 854,212 shares with a market value of roughly $102.75M representing 1.26% of their equity portfolio. The fund/company first acquired MRK in 2019 Q1, initially purchasing about 1.74M shares. Sarah Ketterer later completely sold out the position and reinvested in MRK again in 2024 Q4. Since the initial investment, Causeway Capital Management has made 12 more transactions in this position.
Does Sarah Ketterer still hold MRK?
Yes, Sarah Ketterer continues to hold Merck & Company Inc (MRK). According to their 2026 Q1 report, they maintain a position of 854,212 shares valued at approximately $102.75M, representing 1.26% of their equity portfolio.
When did Sarah Ketterer first invest in MRK?
Sarah Ketterer first invested in Merck & Company Inc (MRK) in 2019 Q1 at the reported quarter-end price of $83.17 per share, acquiring 1,742,969 shares in their initial purchase.
What is Sarah Ketterer's average cost basis for MRK?
Based on historical transaction data, Sarah Ketterer's estimated cost basis for Merck & Company Inc (MRK) is approximately $93.20 per share. This represents their average reported price* across all buy transactions.
Has Sarah Ketterer reinvested in MRK after selling?
Yes, Sarah Ketterer has shown renewed interest in Merck & Company Inc (MRK). After completely selling their position, they reinitiated an investment in 2024 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $93.20
- Weighted AVG sell price:
- $115.49
MRK transactions history by Causeway Capital Management
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.26%
|
854,212
|
$120.29
|
$102,753,243
|
-18.23% (-190,405)
|
-0.32%
|
|
2025 Q4
|
1.51%
|
1,044,617
|
$105.26
|
$109,956,449
|
-7.89% (-89,440)
|
-0.12%
|
|
2025 Q3
|
1.26%
|
1,134,057
|
$83.93
|
$95,181,306
|
+15.41% (+151,397)
|
+0.17%
|
|
2025 Q2
|
1.23%
|
982,660
|
$79.16
|
$77,787,310
|
+9.44% (+84,791)
|
+0.11%
|
|
2025 Q1
|
1.68%
|
897,869
|
$89.76
|
$80,592,684
|
+53.62% (+313,396)
|
+0.59%
|
|
2024 Q4
|
1.32%
|
584,473
|
$99.48
|
$58,143,366
|
new
|
+1.32%
|
|
2020 Q3
|
0.00%
|
$77.33
|
-100% (-814,074)
|
|||
|
2020 Q2
|
1.13%
|
$77.33
|
-44.05% (-640,968)
|
|||
|
2020 Q1
|
1.79%
|
$76.94
|
-17.80% (-315,068)
|
|||
|
2019 Q4
|
1.73%
|
$90.95
|
-3.25% (-59,475)
|
|||
|
2019 Q3
|
1.84%
|
$84.18
|
+3.95% (+69,530)
|
|||
|
2019 Q2
|
1.62%
|
$83.85
|
+0.98% (+17,086)
|
|||
|
2019 Q1
|
1.46%
|
$83.17
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.